Patient Understanding of LiverMultiScan

January 11, 2018 updated by: Perspectum
This is a qualitative study to determine which factors affect the patient experience of having a liver MRI, what information patients would like to receive after their MRI, and how patients would like this information communicated to them.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This is a qualitative study to determine which factors affect the patient experience of having a liver MRI, what information patients would like to receive after their MRI, and how patients would like this information communicated to them. Each individual will receive at least an MRI scan (LiverMultiScan), with many also receiving a FibroScan (Transient Elastography). Patients will then undergo a focused qualitative interview, as well as filling out a questionnaire. The interviews will be thematically analysed and trends identified by significance.

Study Type

Observational

Enrollment (Actual)

101

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United Kingdom
    • Oxfordshire
      • Oxford, Oxfordshire, United Kingdom, OX3 9DU
        • University of Oxford Centre for Clinical Magnetic Resonance Research (OCMR)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Individuals with experience of liver disease, either as a sufferer or carer.

Description

Inclusion Criteria:

  • Individuals with experience of liver disease.
  • Individuals over the age of 16.
  • Individuals willing to give informed consent for participation in the study.

Exclusion Criteria:

  • Individuals with any contraindication to magnetic resonance imaging.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Other

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Experience of liver disease
This is defined as either those who have had direct experience of liver disease as sufferers, or the carers of those who have had liver disease. Each individual receives an MRI (LiverMultiScan), with many also receiving a FibroScan.
Device: MRI
Other Names:
  • LiverMultiScan
Device: Transient Elastography
Other Names:
  • FibroScan

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Factors effecting MRI experience and understanding.
Time Frame: Immediately (within 1 hour) after undergoing the MRI scan, and receiving results feedback.
This will be analysed based on themes and trends emanating from answers within the focused interview and questionnaire following the scan, and results feedback.
Immediately (within 1 hour) after undergoing the MRI scan, and receiving results feedback.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison of MRI to ultrasound scan in terms of patient experience.
Time Frame: Immediately (within 1 hour) after undergoing an MRI scan, and ultrasound (FibroScan) scan.
This will be analysed based on themes and trends emanating from answers within the focused interview and questionnaire following the scan, and results feedback.
Immediately (within 1 hour) after undergoing an MRI scan, and ultrasound (FibroScan) scan.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Perspectum

Investigators

  • Principal Investigator: Rajarshi Banerjee, BM BCh MRCP MSc DPhil, Perspectum Diagnostics

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2016

Primary Completion (Actual)

December 1, 2017

Study Completion (Actual)

December 1, 2017

Study Registration Dates

First Submitted

August 17, 2016

First Submitted That Met QC Criteria

August 19, 2016

First Posted (Estimate)

August 24, 2016

Study Record Updates

Last Update Posted (Actual)

January 12, 2018

Last Update Submitted That Met QC Criteria

January 11, 2018

Last Verified

January 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Patient LMS

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Liver Diseases

Clinical Trials on MRI

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe